1-248180331-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004688.2(OR2M2):c.346G>A(p.Ala116Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004688.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2M2 | NM_001004688.2 | c.346G>A | p.Ala116Thr | missense_variant | 2/2 | ENST00000641836.1 | NP_001004688.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2M2 | ENST00000641836.1 | c.346G>A | p.Ala116Thr | missense_variant | 2/2 | NM_001004688.2 | ENSP00000493201 | P1 | ||
OR2M2 | ENST00000641211.1 | c.346G>A | p.Ala116Thr | missense_variant | 3/3 | ENSP00000492974 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152028Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251444Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135894
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461866Hom.: 0 Cov.: 72 AF XY: 0.0000165 AC XY: 12AN XY: 727230
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.346G>A (p.A116T) alteration is located in exon 1 (coding exon 1) of the OR2M2 gene. This alteration results from a G to A substitution at nucleotide position 346, causing the alanine (A) at amino acid position 116 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at